---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-070114"
form_type: "8-K"
ticker: "EWTX"
cik: "0001710072"
company_name: "Edgewise Therapeutics, Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:05:29.332510+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Edgewise shareholders elect directors, ratify KPMG, approve officer exculpation charter amendment

## Summary
- Elected Class III directors Thompson, Koch, and Fox with 65M–75M shares For vs 6.9M–17.3M Against; broker non-votes 8.2M.
- Ratified KPMG LLP as independent auditor for FY 2024: 90.5M For, 4K Against, 35K Abstain.
- Approved certificate amendment to limit officer liability per Delaware law: 81.4M For, 938K Against, 1.4K Abstain; broker non-votes 8.2M.
- Amendment to Article IX of the certificate of incorporation was filed on June 10, 2024, effective upon filing.

## SEC filing metadata
- accession: 0001104659-24-070114
- form_type: 8-K
- ticker: EWTX
- cik: 0001710072
- company_name: Edgewise Therapeutics, Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/0001104659-24-070114-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1710072/000110465924070114/tm2416817d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-070114
- JSON: https://secwatch.observer/filing/0001104659-24-070114.json
- Plain text: https://secwatch.observer/filing/0001104659-24-070114.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.